What is BioLife Solutions's D&A?

BioLife Solutions (BLFS) reported D&A of $85K in Q1 2026.

How has BioLife Solutions's D&A changed year-over-year?

BioLife Solutions's D&A increased by 28.8% year-over-year, from $66K to $85K.

What is the long-term trend for BioLife Solutions's D&A?

Over 4 years (2021 to 2025), BioLife Solutions's D&A has grown at a -32.2% compound annual growth rate (CAGR), from $8.2M to $1.73M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

BioLife Solutions BLFS D&A

D&A at other companies

Baxter InternationalBAX

$237M-4.0%

ArtivionAORT

$6.34M+16.4%

Charles River LaboratoriesCRL

$67.15M-44.2%

Labcorp HoldingsLH

$75.6M+8.6%

International Flavors & FragrancesIFF

$146M+2.1%

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$27.5M+24.7%

Gross profit$17.5M+18.2%

Operating income$27.0K+105%

Net income$1.2M+365%

EPS (diluted)$0.02—

Balance sheet

See full

Cash & equivalents$22.8M-65.9%

Total debt$17.4M-35.6%

Total equity$372.2M+5.6%

Total assets$400.9M+1.5%

Cash flow

See full

Operating cash flow-$491.0K-128%

CapEx$167.0K-4.6%

Free cash flow-$658.0K-142%

Valuation

See full

Market cap$1.25B+23.8%

Enterprise value$1.24B+28.3%

P/S12.5×-0.4×

Profitability

See full

Gross margin66.9%—

Operating margin-16.7%—

Net margin-68.7%—

FCF margin-15.9%+18.7pp

Returns & leverage

See full

Return on equity-14.5%-4.7pp

Debt / equity0×0.0×

Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioLife Solutions's D&A?: BioLife Solutions (BLFS) reported D&A of $85K in Q1 2026.
How has BioLife Solutions's D&A changed year-over-year?: BioLife Solutions's D&A increased by 28.8% year-over-year, from $66K to $85K.
What is the long-term trend for BioLife Solutions's D&A?: Over 4 years (2021 to 2025), BioLife Solutions's D&A has grown at a -32.2% compound annual growth rate (CAGR), from $8.2M to $1.73M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.